Item Posts Archive - Page 26 of 1770 - Medivizor
Navigation Menu

Evaluating the effectiveness and safety of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Evaluating the effectiveness and safety of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Posted by on Mar 5, 2023 in Prostate cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of rezvilutamide (Ariane) versus bicalutamide (Casodex) in combination with androgen deprivation therapy (ADT) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). The data showed that rezvilutamide in combination with ADT significantly improved the...

Read More

Evaluating the effectiveness and safety of immune checkpoint inhibitors either alone or in combination for the treatment of advanced malignant melanoma.

Evaluating the effectiveness and safety of immune checkpoint inhibitors either alone or in combination for the treatment of advanced malignant melanoma.

Posted by on Mar 5, 2023 in Melanoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of immune checkpoint inhibitors (ICIs) either alone or in combination for the treatment of patients with advanced melanoma. The data showed that nivolumab (Opdivo) and ipilimumab (Yervoy) combination therapy was more effective than nivolumab or ipilimumab alone for the treatment of...

Read More

Evaluating the role of radiotherapy in HER2+ early-stage breast cancer after breast-conserving surgery

Evaluating the role of radiotherapy in HER2+ early-stage breast cancer after breast-conserving surgery

Posted by on Mar 5, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of radiotherapy (RT) in patients with HER2+ early-stage breast cancer (BC) after breast-conserving surgery (BCS). The study found that RT improved the survival rates of these patients, especially for those high-risk. Some background BC is categorized based on the absence or...

Read More

Comparing the effectiveness of vaginal laser therapy and hyaluronic acid suppositories in women with urogenital atrophy after breast cancer treatment

Comparing the effectiveness of vaginal laser therapy and hyaluronic acid suppositories in women with urogenital atrophy after breast cancer treatment

Posted by on Mar 5, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of vaginal laser therapy (VL) and hyaluronic acid suppositories (HAS) in women with urogenital atrophy after having breast cancer (BC) treatment. The data found that both VA therapy and HAS were equally effective in treating urogenital atrophy in these patients. Some background Many women...

Read More

Comparing the effects of different physical and rehabilitation therapies in women with overactive bladder

Comparing the effects of different physical and rehabilitation therapies in women with overactive bladder

Posted by on Mar 5, 2023 in Overactive bladder | 0 comments

In a nutshell The study compared the effects of different physical and rehabilitation therapies in women with overactive bladder (OAB). The study found that percutaneous tibial nerve stimulation (PTNS) alone, a combination of bladder training (BT) with electrical stimulation (ES), and a combination of BT and ES with biofeedback (BF) were effective for...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor